Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YPEG-rhGH in older adults with adult growth hormone deficiency
CTR20213075Phase 2Active
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Dec 2021
- Modality
- PEGylated Peptides → Modified Peptides → Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of inpegsomatropin in adult onset growth hormone deficiency (AGHD), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Dec 2021; status: active.
02
Drugs
inpegsomatropin
03
Conditions
adult onset growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on CTR20213075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213075.